| Parameter | Pre- ERAS group (Jun-12 to Aug-13) | ERAS Group (Dec-13 to Nov-14) | p |
---|---|---|---|---|
Indication for surgery | Colon or rectal cancer, n (%) | 124 (42Â %) | 124 (40Â %) | 0.74 |
Inflammatory bowel disease, n (%) | 87 (29Â %) | 112 (36Â %) | 0.07 | |
Other indication for surgery, n (%) | 94 (32Â %) | 87 (28Â %) | 0.38 | |
Operative approach | Minimally invasive surgery, n (%) | 155 (52Â %) | 184 (59Â %) | 0.073 |
Planned Open surgery, n (%) | 144 (48Â %) | 125 (40Â %) | 0.061 | |
Length of procedure | Median Length of Procedure, Min (Range) | 228 (30–1417) | 196 (39–692) | 0.01 |
Blood loss | Blood loss during surgery Median, ml (range) | 100 ml (0–7800) | 75 ml (0–6000) | 0.58 |